Well-studied, still fully available, and underrated
Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration
Interaction with the nitric oxide (NO) system: BPC-157 modulates nitric oxide synthesis via NO synthase enzymes (eNOS and iNOS)
Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation
State of the clinical research For both compounds, the published clinical research in humans is limited: BPC-157 has not received approval as a medicine in any major regulatory jurisdiction (UK MHRA, EU EMA, US FDA)
In parallel, it alters transcriptional pathways involved in angiogenesis, cytokine production, and tissue remodeling, including PI3K/Akt and NF-B cascades